000950 重药控股
已收盘 10-13 15:00:00
资讯
新帖
简况
股市必读：重药控股新发布《第九届董事会第二十六次会议决议公告》
证券之星 · 10-12 01:41
股市必读：重药控股新发布《第九届董事会第二十六次会议决议公告》
股市必读：重药控股新发布《第九届董事会第二十六次会议决议公告》
证券之星 · 10-09
股市必读：重药控股新发布《第九届董事会第二十六次会议决议公告》
重药控股（000950）披露召开2026年第五次临时股东会的通知，10月08日股价下跌0.38%
证券之星 · 10-08
重药控股（000950）披露召开2026年第五次临时股东会的通知，10月08日股价下跌0.38%
股市必读：重药控股（000950）9月18日董秘有最新回复
证券之星 · 09-21
股市必读：重药控股（000950）9月18日董秘有最新回复
重药控股：公司设有全员绩效考核机制
证券之星 · 09-16
重药控股：公司设有全员绩效考核机制
股市必读：重药控股新发布《北京市竞天公诚律师事务所关于重药控股股份有限公司2026年第四次临时股东会的律师见证法律意见书》
证券之星 · 09-14
股市必读：重药控股新发布《北京市竞天公诚律师事务所关于重药控股股份有限公司2026年第四次临时股东会的律师见证法律意见书》
重药控股（000950）披露2026年第四次临时股东会决议公告，9月10日股价下跌1.31%
证券之星 · 09-10
重药控股（000950）披露2026年第四次临时股东会决议公告，9月10日股价下跌1.31%
重药控股：公司高度重视医保基金与医药企业直接结算政策的落地推进
证券之星 · 09-10
重药控股：公司高度重视医保基金与医药企业直接结算政策的落地推进
通用技术重药控股与碧迪医疗正式开启战略合作
同花顺 · 09-08
通用技术重药控股与碧迪医疗正式开启战略合作
重药控股（000950）披露董事、副总经理离任公告，9月2日股价下跌1.09%
证券之星 · 09-02
重药控股（000950）披露董事、副总经理离任公告，9月2日股价下跌1.09%
重药控股：8月28日召开业绩说明会，投资者参与
证券之星 · 08-28
重药控股：8月28日召开业绩说明会，投资者参与
重药控股（000950）2026年中报简析：净利润同比下降9.85%
证券之星 · 08-27
重药控股（000950）2026年中报简析：净利润同比下降9.85%
重药控股（000950）披露2026年半年度报告，8月25日股价上涨3.14%
证券之星 · 08-25
重药控股（000950）披露2026年半年度报告，8月25日股价上涨3.14%
垫资供货讨债难！重药控股422起诉讼涉12.89亿元，百亿元应收压身，医院欠款顽疾能否化解
市场资讯 · 08-14
垫资供货讨债难！重药控股422起诉讼涉12.89亿元，百亿元应收压身，医院欠款顽疾能否化解
股市必读：重药控股新发布《关于新增累计诉讼、仲裁案件情况的公告》
证券之星 · 08-06
股市必读：重药控股新发布《关于新增累计诉讼、仲裁案件情况的公告》
重药控股（000950）披露新增累计诉讼、仲裁案件情况，8月4日股价上涨1.27%
证券之星 · 08-04
重药控股（000950）披露新增累计诉讼、仲裁案件情况，8月4日股价上涨1.27%
重药控股与翰森制药正式启动新丰翼项目战略合作
南方财经网 · 07-23
重药控股与翰森制药正式启动新丰翼项目战略合作
重药控股：主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业
证券之星 · 07-16
重药控股：主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业
股市必读：重药控股（000950）7月13日董秘有最新回复
证券之星 · 07-14
股市必读：重药控股（000950）7月13日董秘有最新回复
重药控股：以医药流通为核心业务
证券之星 · 07-13
重药控股：以医药流通为核心业务
加载更多
公司概况
公司名称：
重药控股股份有限公司
所属行业：
批发业
上市日期：
1999-09-16
主营业务：
重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品、医疗器械、中药饮片、健康品。
发行价格：
4.63
{"stockData":{"symbol":"000950","market":"SZ","secType":"STK","nameCN":"重药控股","latestPrice":5.29,"timestamp":1791875001000,"preClose":5.32,"halted":0,"volume":15922500,"delay":0,"changeRate":-0.0056,"floatShares":1713000000,"shares":1713000000,"eps":0.2096,"marketStatus":"已收盘","change":-0.03,"latestTime":"10-13 15:00:00","open":5.3,"high":5.32,"low":5.24,"amount":84157100,"amplitude":0.015,"askPrice":5.29,"askSize":1196,"bidPrice":5.28,"bidSize":1251,"shortable":0,"etf":0,"ttmEps":0.2096,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.32,"symbolType":"stock","openAndCloseTimeList":[[1791855000000,1791862200000],[1791867600000,1791874800000]],"highLimit":5.85,"lowLimit":4.79,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1712778096,"isCdr":false,"pbRate":0.78,"roa":"--","peRate":25.23855,"roe":"2.18%","epsLYR":0.22,"committee":0.364578,"marketValue":9061000000,"turnoverRate":0.0093,"status":1,"floatMarketCap":9061000000},"requestUrl":"/m/hq/s/000950","defaultTab":"news","newsList":[{"id":"2674843023","title":"股市必读：重药控股新发布《第九届董事会第二十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674843023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674843023?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:41","pubTimestamp":1791740466,"startTime":"0","endTime":"0","summary":"本次发行需经公司股东会审议，并获相关主管部门批准后实施；董事会提请股东会授权管理层办理发行相关事宜。关于调整董事的公告重药控股董事会于2026年10月8日收到魏云辞去董事及战略与可持续发展委员会委员职务的报告，辞职后不再担任公司任何职务；同日董事会审议通过增补潘臻、刘全喜为第九届董事会非独立董事候选人，任期自股东会审议通过之日起至本届董事会任期届满；二人均未持有公司股份，任职资格符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674028630","title":"股市必读：重药控股新发布《第九届董事会第二十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674028630","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674028630?lang=zh_cn&edition=full","pubTime":"2026-10-09 02:25","pubTimestamp":1791483912,"startTime":"0","endTime":"0","summary":"公司公告汇总：控股子公司拟新增对两家下属公司担保额度合计5,110万元，调整后对外担保总额占净资产23.41%。关于调整董事的公告重药控股董事会于2026年10月8日收到魏云辞去董事及战略与可持续发展委员会委员职务的报告，辞职后不再担任公司任何职务；同日董事会审议通过增补潘臻、刘全喜为第九届董事会非独立董事候选人，任期自股东会审议通过之日起至本届董事会任期届满；二人均未持有公司股份，任职资格符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673005312","title":"重药控股（000950）披露召开2026年第五次临时股东会的通知，10月08日股价下跌0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673005312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673005312?lang=zh_cn&edition=full","pubTime":"2026-10-08 22:35","pubTimestamp":1791470116,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，重药控股报收于5.23元，较前一交易日下跌0.38%，最新总市值为89.58亿元。该股当日开盘5.25元，最高5.3元，最低5.2元，成交额达8229.54万元，换手率为0.91%。近日，重药控股股份有限公司披露《关于召开2026年第五次临时股东会的通知》。公告显示，公司将于2026年10月28日召开2026年第五次临时股东会，会议由董事会召集，现场会议地点为重庆市两江新区金石大道303号公司会议室。股权登记日为2026年10月23日。公司将对中小股东进行单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800034708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669829171","title":"股市必读：重药控股（000950）9月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2669829171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669829171?lang=zh_cn&edition=full","pubTime":"2026-09-21 01:00","pubTimestamp":1789923641,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，重药控股报收于5.21元，上涨0.77%，换手率0.72%，成交量12.38万手，成交额6460.75万元。董秘最新回复投资者： 请问如果公司管理层有绩效考核的话，那么最近几年的战略失误是如何体现到绩效上的呢？当日关注点交易信息汇总：9月18日主力资金净流入65.76万元，占总成交额1.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100000549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667038576","title":"重药控股：公司设有全员绩效考核机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2667038576","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667038576?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:15","pubTimestamp":1789542921,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司有绩效考核吗？管理层参与绩效考核吗？重药控股回复：尊敬的投资者您好，公司设有全员绩效考核机制，管理层参与绩效考核。董事会薪酬与考核委员会负责董事、高管考核工作，经理层落实任期制契约化管理，考核结果与绩效薪酬挂钩。《董事、高级管理人员薪酬管理制度》《董事会薪酬与考核委员会工作细则》等相关文件已在巨潮资讯网公开披露。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600018870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667680477","title":"股市必读：重药控股新发布《北京市竞天公诚律师事务所关于重药控股股份有限公司2026年第四次临时股东会的律师见证法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667680477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667680477?lang=zh_cn&edition=full","pubTime":"2026-09-14 02:24","pubTimestamp":1789323853,"startTime":"0","endTime":"0","summary":"公司公告汇总：重药控股2026年第四次临时股东会于9月10日召开，审议通过关于变更注册资本、注册地址暨修订《公司章程》的议案，同意股份数占出席会议有效表决权股份总数的99.7247%。律师认为本次股东会相关事项符合法律法规及公司章程规定，决议合法有效。出席会议股东共307人，代表股份占公司有表决权股份总数的59.5375%；其中中小股东305人，代表股份占公司有表决权股份总数的4.2358%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591225","title":"重药控股（000950）披露2026年第四次临时股东会决议公告，9月10日股价下跌1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591225?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:29","pubTimestamp":1789050553,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，重药控股报收于5.29元，较前一交易日下跌1.31%，最新总市值为90.61亿元。近日，重药控股发布2026年第四次临时股东会决议公告。其中，中小股东305人，代表股份占公司有表决权股份总数的4.2358%。议案获得总表决同意股数占比99.7247%，中小股东同意占比96.1308%。本次会议决议合法有效，无否决提案情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666561655","title":"重药控股：公司高度重视医保基金与医药企业直接结算政策的落地推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666561655?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:51","pubTimestamp":1789001473,"startTime":"0","endTime":"0","summary":"公司是否已经观察到相关区域新增应收账款、DSO或逾期应收占比出现改善？如具体金额不便透露，请说明下目前状态与未来的主要扩围方向，感谢重药控股回复：尊敬的投资者您好，公司高度重视医保基金与医药企业直接结算政策的落地推进。公司下游客户以等级医院为主，应收账款坏账风险整体可控；公司通过强化应收考核、严控 “两金”规模、加强采购管理、完善客户资信管理、建立常态化及分层催收机制，加快款项回收。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000007153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328417","title":"通用技术重药控股与碧迪医疗正式开启战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328417","media":"同花顺","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665328417?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:36","pubTimestamp":1788852960,"startTime":"0","endTime":"0","summary":"9月7日，通用技术重药控股与碧迪医疗召开“碧迪滴D 联商共赢”业务沟通会，正式签署战略合作协议。重药控股高级副总裁、党委委员李少宏，高级副总裁张欣，碧迪医疗大中华区渠道卓越部副总裁 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/20260908/c679696373.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20260908/c679696373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664810215","title":"重药控股（000950）披露董事、副总经理离任公告，9月2日股价下跌1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664810215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664810215?lang=zh_cn&edition=full","pubTime":"2026-09-02 23:02","pubTimestamp":1788361341,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，重药控股报收于5.46元，较前一交易日下跌1.09%，最新总市值为93.52亿元。近日，重药控股股份有限公司发布关于董事、副总经理离任的公告。公告显示，公司于2026年9月1日收到董事、副总经理陈义海先生的辞职报告。陈义海先生原定任期至第九届董事会任期届满，其转任不影响公司正常运作。截至公告日，陈义海先生未持有公司股份，不存在应履行而未履行的承诺事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662509983","title":"重药控股：8月28日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509983","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662509983?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:02","pubTimestamp":1787925762,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月28日重药控股发布公告称公司于2026年8月28日召开业绩说明会。重药控股2026年中报显示，上半年度公司主营收入401.32亿元，同比下降2.57%；归母净利润2.54亿元，同比下降9.85%；扣非净利润2.43亿元，同比下降12.37%；其中2026年第二季度，公司单季度主营收入196.99亿元，同比下降4.26%；单季度归母净利润8372.19万元，同比下降46.68%；单季度扣非净利润7636.14万元，同比下降50.72%；负债率75.45%，投资收益1.39亿元，财务费用3.23亿元，毛利率6.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800053418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0250","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740746","title":"重药控股（000950）2026年中报简析：净利润同比下降9.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740746","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740746?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:23","pubTimestamp":1787783009,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期重药控股发布2026年中报。根据财报显示，重药控股净利润同比下降9.85%。截至本报告期末，公司营业总收入401.32亿元，同比下降2.57%，归母净利润2.54亿元，同比下降9.85%。按单季度数据看，第二季度营业总收入196.99亿元，同比下降4.26%，第二季度归母净利润8372.19万元，同比下降46.68%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700011576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662753655","title":"重药控股（000950）披露2026年半年度报告，8月25日股价上涨3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662753655","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662753655?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:41","pubTimestamp":1787668887,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，重药控股报收于5.58元，较前一交易日上涨3.14%，最新总市值为95.57亿元。该股当日开盘5.4元，最高5.6元，最低5.37元，成交额达2.01亿元，换手率为2.13%。近日，重药控股披露《2026年半年度报告》。报告显示，报告期内公司实现营业收入401.32亿元，同比下降2.57%；归属于上市公司股东的净利润为2.54亿元，同比下降9.85%；扣除非经常性损益后的净利润为2.43亿元，同比下降12.37%。基本每股收益为0.15元，稀释每股收益为0.15元，分别同比下降6.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500051536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659192560","title":"垫资供货讨债难！重药控股422起诉讼涉12.89亿元，百亿元应收压身，医院欠款顽疾能否化解","url":"https://stock-news.laohu8.com/highlight/detail?id=2659192560","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659192560?lang=zh_cn&edition=full","pubTime":"2026-08-14 10:08","pubTimestamp":1786673280,"startTime":"0","endTime":"0","summary":"其中重药（辽宁）有限公司、辽宁卫生服务有限公司分别起诉北票市中心医院，两笔欠款合计超4100万元；重庆医药集团陕西有限公司起诉渭南市临渭区中医医院涉案金额2520.96万元，起诉渭南市第二医院涉案金额1091.59万元；陕西华氏医药有限公司起诉渭南市精神病医院，逾期货款1072.19万元，上述医院相关案件均已出具生效民事调解书。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-14/doc-ininfvzs4257205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657213015","title":"股市必读：重药控股新发布《关于新增累计诉讼、仲裁案件情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657213015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657213015?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:23","pubTimestamp":1785950589,"startTime":"0","endTime":"0","summary":"交易信息汇总资金流向8月5日主力资金净流入802.52万元，占总成交额2.86%；游资资金净流入2125.81万元，占总成交额7.57%；散户资金净流出2928.33万元，占总成交额10.42%。公司公告汇总关于新增累计诉讼、仲裁案件情况的公告重药控股股份有限公司公告，公司及控股子公司连续十二个月内新增尚未披露的诉讼、仲裁案件涉案金额共计128,878.07万元，占公司最近一期经审计归属于母公司净资产的11.17%。部分案件已作出一审判决或达成调解，部分仍在审理中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656355427","title":"重药控股（000950）披露新增累计诉讼、仲裁案件情况，8月4日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656355427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656355427?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:11","pubTimestamp":1785852687,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，重药控股报收于5.57元，较前一交易日上涨1.27%，最新总市值为95.4亿元。近日，重药控股股份有限公司发布《关于新增累计诉讼、仲裁案件情况的公告》。公告显示，公司及控股子公司连续十二个月内新增尚未披露的诉讼、仲裁案件涉案金额共计128,878.07万元，占公司最近一期经审计归属于母公司净资产的11.17%。无单项金额超过1,000万元且占净资产10%以上的重大诉讼、仲裁事项。部分案件已作出一审判决或达成调解，部分仍在审理中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653184027","title":"重药控股与翰森制药正式启动新丰翼项目战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2653184027","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653184027?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:07","pubTimestamp":1784776020,"startTime":"0","endTime":"0","summary":"南方财经7月23日电，据重药控股消息，7月22日，重药控股与翰森制药集团有限公司召开新丰翼项目签约会。根据协议，本次项目合作将覆盖重庆、河南、陕西、贵州、四川、甘肃、天津、宁夏、湖北9个省市。双方将整合自身优质资源，在市场准入、新兴业务等重点合作领域持续深化协同，打造产销一体化创新合作体系。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607233818638391.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607233818638391.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","000950","BK0071","BK1589","BK0250","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651411685","title":"重药控股：主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业","url":"https://stock-news.laohu8.com/highlight/detail?id=2651411685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651411685?lang=zh_cn&edition=full","pubTime":"2026-07-16 15:03","pubTimestamp":1784185395,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，实验猴子价格越来越贵，会不会影响公司对创新药的研发？影响公司发展？重药控股回复：公司处于医药流通行业，主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业，其中医药流通为核心业务；医药研发主要以药品上市许可持有人的方式开展，目前以高端仿制药和特色现代中药为主。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600019000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK1574","BK1583","000950","BK1100","BK1515","09996","09939","159883","159938","BK0071","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651753146","title":"股市必读：重药控股（000950）7月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651753146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651753146?lang=zh_cn&edition=full","pubTime":"2026-07-14 02:19","pubTimestamp":1783966749,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，重药控股报收于5.29元，上涨2.12%，换手率2.6%，成交量44.48万手，成交额2.36亿元。董秘最新回复投资者： 尊敬的董秘。交易信息汇总资金流向7月13日主力资金净流出165.05万元，占总成交额0.0%；游资资金净流出20.87万元；散户资金净流入185.92万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400001669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651119431","title":"重药控股：以医药流通为核心业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2651119431","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651119431?lang=zh_cn&edition=full","pubTime":"2026-07-13 16:03","pubTimestamp":1783929797,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘。贵公司有什么科技业务没？也可以收购些半导体芯片行业的做下转型升级的。重药控股回复：公司处于医药流通行业，主要从事医药流通、医药研发（MAH）、医疗器械生产并投资参与医药工业，其中以医药流通为核心业务。感谢您的关注与建议！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300022098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK1161","159938","BK1515","09939","BK0071","000950","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791880279248,"stockEarnings":[{"period":"1week","weight":0.0133},{"period":"1month","weight":0.025},{"period":"3month","weight":-0.013},{"period":"6month","weight":-0.1573},{"period":"1year","weight":0.0399},{"period":"ytd","weight":-0.0762}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0234},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重药控股股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"48253人(较上一季度减少7.33%)","perCapita":"35495股","listingDate":"1999-09-16","address":"重庆市两江新区金石大道303号","registeredCapital":"171277万元","survey":" 重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品、医疗器械、中药饮片、健康品。","listedPrice":4.63},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"重药控股,000950,重药控股股票,重药控股股票老虎,重药控股股票老虎国际,重药控股行情,重药控股股票行情,重药控股股价,重药控股股市,重药控股股票价格,重药控股股票交易,重药控股股票购买,重药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}